IL76732A - Injectable pharmaceutical compositions containing lyophilized anthracycline glycosides,their preparation and some new such lyophilized compositions - Google Patents

Injectable pharmaceutical compositions containing lyophilized anthracycline glycosides,their preparation and some new such lyophilized compositions

Info

Publication number
IL76732A
IL76732A IL76732A IL7673285A IL76732A IL 76732 A IL76732 A IL 76732A IL 76732 A IL76732 A IL 76732A IL 7673285 A IL7673285 A IL 7673285A IL 76732 A IL76732 A IL 76732A
Authority
IL
Israel
Prior art keywords
lyophilized
preparation
new
injectable pharmaceutical
pharmaceutical compositions
Prior art date
Application number
IL76732A
Other languages
English (en)
Other versions
IL76732A0 (en
Inventor
Gatti Gaetano
Oldani Diego
Confalonieri Carlo
Gambini Luciano
Original Assignee
Erba Carlo Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Erba Carlo Spa filed Critical Erba Carlo Spa
Publication of IL76732A0 publication Critical patent/IL76732A0/xx
Publication of IL76732A publication Critical patent/IL76732A/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A61K31/704Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12Carboxylic acids; Salts or anhydrides thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183Amino acids, e.g. glycine, EDTA or aspartame
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/20Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Saccharide Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IL76732A 1984-10-22 1985-10-17 Injectable pharmaceutical compositions containing lyophilized anthracycline glycosides,their preparation and some new such lyophilized compositions IL76732A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB848426672A GB8426672D0 (en) 1984-10-22 1984-10-22 Pharmaceutical compositions

Publications (2)

Publication Number Publication Date
IL76732A0 IL76732A0 (en) 1986-02-28
IL76732A true IL76732A (en) 1989-07-31

Family

ID=10568553

Family Applications (1)

Application Number Title Priority Date Filing Date
IL76732A IL76732A (en) 1984-10-22 1985-10-17 Injectable pharmaceutical compositions containing lyophilized anthracycline glycosides,their preparation and some new such lyophilized compositions

Country Status (35)

Country Link
US (4) US4675311A (nl)
JP (1) JPH0611700B2 (nl)
KR (1) KR920005813B1 (nl)
CN (1) CN85107562B (nl)
AT (1) AT401345B (nl)
AU (1) AU572003B2 (nl)
BE (1) BE903484A (nl)
BG (1) BG60934B2 (nl)
CA (1) CA1248453A (nl)
CH (1) CH667594A5 (nl)
CS (1) CS270421B2 (nl)
DE (1) DE3536896C2 (nl)
DK (1) DK165620C (nl)
ES (1) ES8605374A1 (nl)
FI (2) FI853913A (nl)
FR (1) FR2571966B1 (nl)
GB (2) GB8426672D0 (nl)
GR (1) GR852549B (nl)
HK (1) HK94390A (nl)
HU (1) HU197988B (nl)
IE (1) IE56992B1 (nl)
IL (1) IL76732A (nl)
IT (1) IT1186779B (nl)
MY (1) MY103956A (nl)
NL (1) NL191308C (nl)
NO (1) NO170616C (nl)
NZ (1) NZ213885A (nl)
PH (1) PH23982A (nl)
PT (1) PT81347B (nl)
RU (2) RU1836088C (nl)
SE (1) SE467520B (nl)
SG (1) SG80290G (nl)
UA (2) UA34419C2 (nl)
YU (1) YU46160B (nl)
ZA (1) ZA858033B (nl)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5124318A (en) * 1985-08-02 1992-06-23 Farmitalia Carlo Erba S.R.L. Injectable ready-to-use solutions containing an antitumor anthracycline glycoside
US5124317A (en) * 1985-08-02 1992-06-23 Farmitalia Carlo Erba S.P.A. Injectable ready-to-use solutions containing an antitumor anthracycline glycoside
US5977082A (en) * 1985-08-02 1999-11-02 Pharmacia & Upjohn Company Injectable ready-to-use solutions containing an antitumor anthracycline glycoside
ATE129896T1 (de) * 1986-12-05 1995-11-15 Pharmacia Spa Anthracyclin-glucosid enthaltende einspritzbare gebrauchsfertige lösungen gegen krebs.
JP2603480B2 (ja) * 1987-08-05 1997-04-23 住友製薬株式会社 安定化されたアンスラサイクリン系製剤
DE3801178A1 (de) * 1988-01-18 1989-07-27 Hoechst Ag Stabilisierte trockenzubereitung zytostatisch wirksamer anthracyclin-antibiotika und verfahren zu ihrer herstellung
US6300362B1 (en) 1990-07-25 2001-10-09 Novartis Ag (Formerly Sandoz Ltd.) Stabilized pharmaceutical compositions comprising acid donors
CA2275889C (en) 1996-12-30 2008-03-18 Battelle Memorial Institute Formulation and method for treating neoplasms by inhalation
US5942508A (en) * 1997-02-04 1999-08-24 Senju Pharmaceutical Co., Ltd. Method for solubilizing pyridonecarboxylic acid solubilizer thereof and aqueous solution containing solubilized pyridonecarboxylic acid
SG161101A1 (en) 2002-02-22 2010-05-27 Schering Corp Pharmaceutical formulations of antineoplastic agents, in particular temozolomide processes of making and using the same
EP1474995B1 (en) * 2003-05-06 2012-11-14 Gumlink A/S A method for producing chewing gum granules, a gum composition extruder and granulating system, and a chewing gum product
WO2005004805A2 (en) * 2003-07-02 2005-01-20 Solux Corporation Thermally stable crystalline epirubicin hydrochloride and method of making the same
US20090099346A1 (en) * 2003-07-02 2009-04-16 Victor Matvienko Thermally stable crystalline epirubicin hydrochloride
ES2425083T3 (es) * 2003-09-25 2013-10-11 Astellas Pharma Inc. Agente antitumoral que comprende FK228 como inhibidor de histona desacetilasa y doxorrubicina como inhibidor de topoisomerasa II
US7388083B2 (en) * 2005-03-07 2008-06-17 Solux Corporation Epimerization of 4′-C bond and modification of 14-CH3-(CO)-fragment in anthracyclin antibiotics
US20070004653A1 (en) * 2005-05-11 2007-01-04 Roberto Arosio Stable lyophilized anthracycline glycosides
ATE552032T1 (de) 2005-07-14 2012-04-15 Lithera Inc Verbesserte lipolytikum-formulierung mit hinhaltender wirkstofffreigabe für die arealbehandlung von fettgewebe
EP1976858B1 (en) * 2005-12-13 2016-01-06 Solux Corporation Method for preparing 4-demethyldaunorubicin
US8802830B2 (en) * 2005-12-20 2014-08-12 Solux Corporation Synthesis of epirubicin from 13-dihydrodaunorubicine
US8148338B2 (en) * 2006-02-22 2012-04-03 Supratek Pharma Inc. Doxorubicin formulations for anti-cancer use
US7470672B2 (en) * 2006-07-31 2008-12-30 Savvipharm Inc. Compositions and methods of reducing tissue levels of drugs when given as orotate derivatives
CA2687291A1 (en) * 2007-05-16 2008-11-20 Ktb Tumorforschungsgesellschaft Mbh Low-viscous anthracycline formulation
US8227430B2 (en) 2007-09-04 2012-07-24 Meiji Seika Pharma Co., Ltd Injectable, injection solution, and injection kit preparation
EP2211869A2 (en) * 2007-10-26 2010-08-04 Pfizer Products Inc. Idarubicin for the treatment of lymphoma in a dog
US8357785B2 (en) * 2008-01-08 2013-01-22 Solux Corporation Method of aralkylation of 4′-hydroxyl group of anthracylins
US9132084B2 (en) 2009-05-27 2015-09-15 Neothetics, Inc. Methods for administration and formulations for the treatment of regional adipose tissue
SG182485A1 (en) * 2010-01-15 2012-08-30 Lithera Inc Lyophilized cake formulations
GB2485885B (en) 2010-11-24 2015-06-17 Neothetics Inc Selective, lipophilic, and long-acting beta agonist monotherapeutic formulations and methods for the cosmetic treatment of adiposity and contour bulging
DE102011103751A1 (de) 2011-05-31 2012-12-06 Heraeus Precious Metals Gmbh & Co. Kg Kristallisierung von Epirubicinhydrochlorid
DE102011111991A1 (de) * 2011-08-30 2013-02-28 Lead Discovery Center Gmbh Neue Cyclosporin-Derivate
DK2931042T3 (da) 2012-12-13 2021-06-07 Cytrx Corp Anthracyclinformuleringer
KR102257647B1 (ko) 2013-06-05 2021-05-31 싸이트알엑스 코포레이션 암 치료용 세포독성제

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
YU33730B (en) * 1967-04-18 1978-02-28 Farmaceutici Italia Process for preparing a novel antibiotic substance and salts thereof
US4039663A (en) * 1975-03-19 1977-08-02 Societa' Farmaceutici Italia S.P.A. Daunomycins, process for their uses and intermediates
GB1506200A (en) * 1975-04-30 1978-04-05 Farmaceutici Italia Glycosides
GB1567456A (en) * 1976-11-16 1980-05-14 Farmaceutici Italia Daunomycin derivatives
GB2007645B (en) * 1977-10-17 1982-05-12 Stanford Res Inst Int Benzyl anthracyclines and pharmaceutical compositions containing them
US4177264A (en) * 1977-10-17 1979-12-04 Sri International N-benzyl anthracyclines
JPS563851A (en) * 1979-06-22 1981-01-16 Matsushita Electric Works Ltd Fireplace in floor
JPS5756494A (en) * 1980-09-22 1982-04-05 Microbial Chem Res Found New anthracyclin derivative
US4325947A (en) * 1981-05-12 1982-04-20 Farmitalia Carlo Erba S.P.A. 4-Demethoxy-4'-deoxydoxorubicin
IT1210476B (it) * 1981-05-28 1989-09-14 Erba Farmitalia Antracicline.
US4438105A (en) * 1982-04-19 1984-03-20 Farmaitalia Carlo Erba S.P.A 4'-Iododerivatives of anthracycline glycosides
DE3317702A1 (de) * 1982-05-24 1983-11-24 Farmitalia Carlo Erba S.p.A., 20159 Milano Anthracyclinglykoside, verfahren zu deren herstellung und arzneimittel, welche diese enthalten
US4464529A (en) * 1982-07-20 1984-08-07 Sri International Analogues of morpholinyl daunorubicin and morpholinyl doxorubicin
CA1248944A (en) * 1982-09-28 1989-01-17 Gareth J. Thomas Anthracycline glycosides
JPS5982395A (ja) * 1982-11-02 1984-05-12 Microbial Chem Res Found アントラサイクリン化合物、その製造法およびその用途
GR79729B (nl) * 1982-12-20 1984-10-31 Univ Ohio State Res Found
JPS6092212A (ja) * 1983-10-26 1985-05-23 Kyowa Hakko Kogyo Co Ltd ドキソルビシン塩の製剤
US4537882A (en) * 1984-05-10 1985-08-27 Ohio State University 4-Demethoxy-3'-desamino-2'-halo-anthracycline and pharmaceutical composition containing same

Also Published As

Publication number Publication date
HK94390A (en) 1990-11-23
NL191308B (nl) 1994-12-16
ES8605374A1 (es) 1986-03-16
NL8502869A (nl) 1986-05-16
FI86252B (fi) 1992-04-30
CS270421B2 (en) 1990-06-13
GB8426672D0 (en) 1984-11-28
DK481585D0 (da) 1985-10-21
UA19169A (uk) 1997-12-25
IE56992B1 (en) 1992-02-26
CS756585A2 (en) 1989-11-14
FI86252C (fi) 1992-08-10
YU164485A (en) 1987-10-31
DK481585A (da) 1986-04-23
NZ213885A (en) 1988-05-30
IE852593L (en) 1986-04-22
SE8504945D0 (sv) 1985-10-21
IT8522507A0 (it) 1985-10-16
DE3536896C2 (de) 1996-11-14
FI854035L (fi) 1986-04-23
FI853913A (fi) 1986-04-23
FI853913A0 (fi) 1985-10-08
GB8525709D0 (en) 1985-11-20
JPS61246129A (ja) 1986-11-01
FR2571966B1 (fr) 1988-04-15
FI854035A0 (fi) 1985-10-16
MY103956A (en) 1993-10-30
KR920005813B1 (ko) 1992-07-20
GR852549B (nl) 1986-02-24
FR2571966A1 (fr) 1986-04-25
AT401345B (de) 1996-08-26
HUT40759A (en) 1987-02-27
CN85107562B (zh) 1988-06-01
DE3536896A1 (de) 1986-04-24
AU4880585A (en) 1986-05-01
DK165620C (da) 1993-06-01
NL191308C (nl) 1995-05-16
BG60934B2 (bg) 1996-06-28
SG80290G (en) 1990-11-23
RU1836088C (ru) 1993-08-23
ES547578A0 (es) 1986-03-16
US4675311A (en) 1987-06-23
UA34419C2 (uk) 2001-03-15
SE467520B (sv) 1992-08-03
GB2165751A (en) 1986-04-23
CN85107562A (zh) 1986-07-23
CH667594A5 (de) 1988-10-31
PT81347B (pt) 1987-11-11
HU197988B (en) 1989-07-28
PT81347A (en) 1985-11-01
IT1186779B (it) 1987-12-16
US4840938A (en) 1989-06-20
ZA858033B (en) 1986-06-25
US5091372A (en) 1992-02-25
SE8504945L (sv) 1986-04-23
DK165620B (da) 1992-12-28
RU2101018C1 (ru) 1998-01-10
YU46160B (sh) 1993-05-28
ATA303285A (de) 1996-01-15
GB2165751B (en) 1988-08-17
NO170616C (no) 1992-11-11
NO170616B (no) 1992-08-03
US5091373A (en) 1992-02-25
KR860003014A (ko) 1986-05-19
JPH0611700B2 (ja) 1994-02-16
IL76732A0 (en) 1986-02-28
PH23982A (en) 1990-02-09
AU572003B2 (en) 1988-04-28
CA1248453A (en) 1989-01-10
BE903484A (fr) 1986-04-21
NO854194L (no) 1986-04-23

Similar Documents

Publication Publication Date Title
IL76732A (en) Injectable pharmaceutical compositions containing lyophilized anthracycline glycosides,their preparation and some new such lyophilized compositions
IL75197A0 (en) Aminotetralin derivatives,their preparation and pharmaceutical compositions containing them
IL75030A (en) Phenol derivatives,their preparation and pharmaceutical compositions comprising them
IL74153A (en) 6-alkylidene penems,their preparation and pharmaceutical compositions comprising them
IL65858A (en) 4-demethoxy-6(11)-deoxy-doxorubicin and daunorubicin derivatives,their preparation and pharmaceutical compositions containing them
IL75966A0 (en) 3-substituted-1-aminoalkyl-1h-indoles,their preparation and pharmaceutical compositions containing them
IL76823A0 (en) 1,2,4-triazolo-carbamates,their preparation and pharmaceutical compositions containing them
IL84146A0 (en) Anthracycline glycosides,their preparation and pharmaceutical compositions containing them
IL76956A0 (en) Antibiotic polypeptide,its preparation and pharmaceutical compositions containing it
IL82820A0 (en) Anthracycline glycosides,their preparation and pharmaceutical compositions containing them
EP0159652A3 (en) 4-phenylphthalazine derivatives, their preparation and pharmaceutical compositions containing them
DE3573784D1 (en) Carboxyalkyldipeptides, their preparation and pharmaceutical compositions containing them
DE3561808D1 (en) Phenylnonatetraenic-acid derivatives, their preparation and pharmaceutical compositions containing them
IL93478A0 (en) Steroid diols,pharmaceutical compositions containing them and their preparation
IL69778A0 (en) Anthracycline glycosides,their manufacture and pharmaceutical compositions containing them
NZ218256A (en) Anthracycline glycosides and pharmaceutical compositions
IL63287A0 (en) Anthracycline glycosides,their preparation and pharmaceutical compositions containing them
IL93676A0 (en) Anthracycline derivatives,their preparation and pharmaceutical compositions containing them
IL88311A0 (en) 4-demethoxy anthracycline derivatives,their preparation and pharmaceutical compositions containing them
IL104974A0 (en) Anthracycline glycosides,their preparation and pharmaceutical compositions containing them
IL104975A0 (en) Anthracycline glycosides,their preparation and pharmaceutical compositions containing them
DE3570667D1 (en) 3-aminopropyloxyphenyl derivatives, their preparation and pharmaceutical compositions containing them
IL67709A (en) Daunorubicin and doxorubicin analogues,their preparation and pharmaceutical compositions containing them
IL74776A0 (en) Eburnane derivatives,their preparation and pharmaceutical compositions containing them
IL83228A0 (en) 6-deoxyanthracycline glycosides,their preparation and pharmaceutical compositions containing them

Legal Events

Date Code Title Description
HC Change of name of proprietor(s)
FF Patent granted
KB Patent renewed
KB Patent renewed
HP Change in proprietorship
EXP Patent expired